Cocrystal Pharma (COCP) Current Leases (2018 - 2026)

Cocrystal Pharma (COCP) reported Current Leases of $343000.0 for Q1 2026, up 11.0% on a YoY basis from $309000.0 in Q1 2025, and up 2.69% sequentially from $334000.0 in Q4 2025.

Cocrystal Pharma (COCP) Current Leases (2018 - 2026) Analysis & Trends

Cocrystal Pharma (COCP) has 9 years of Current Leases data on file, last reported at $343000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 11.0% year-over-year to $343000.0; the trailing twelve-month figure through Mar 2026 stood at $343000.0 (up 11.0% YoY), and the FY2025 full-year result was $334000.0, up 10.96% from the prior year.
  • Current Leases climbed to $343000.0 in Q1 2026, from $334000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $343000.0 in Q1 2026 to a low of $14000.0 in Q3 2022.
  • A 5-year average of $231117.6 and a median of $240000.0 in 2023 frame the typical range for Current Leases.
  • Across the five-year window, Current Leases slumped 51.72% in 2022 and soared 742.86% in 2023, its largest moves.
  • Tracing COCP's Current Leases over 5 years: stood at $233000.0 in 2022, then increased by 3.0% to $240000.0 in 2023, then increased by 25.42% to $301000.0 in 2024, then gained by 10.96% to $334000.0 in 2025, then increased by 2.69% to $343000.0 in 2026.
  • Business Quant data shows COCP's Current Leases at $343000.0 in Q1 2026, $334000.0 in Q4 2025, and $326000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 531,233.95
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 20.58 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 11.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 16.61 Mn
10 Cocrystal Pharma 12.57 Mn 7.74 Mn - 343,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 343,000.00
Dec 31, 2025 334,000.00
Sep 30, 2025 326,000.00
Jun 30, 2025 317,000.00
Mar 31, 2025 309,000.00
Dec 31, 2024 301,000.00
Sep 30, 2024 293,000.00
Jun 30, 2024 251,000.00
Mar 31, 2024 240,000.00
Dec 31, 2023 240,000.00
Sep 30, 2023 118,000.00
Jun 30, 2023 166,000.00
Mar 31, 2023 208,000.00
Dec 31, 2022 233,000.00
Sep 30, 2022 14,000.00
Jun 30, 2022 21,000.00
Mar 31, 2022 215,000.00
Dec 31, 2021 209,000.00
Sep 30, 2021 29,000.00
Jun 30, 2021 33,000.00